FONAR Corporation (FONR) Financials
Stock symbol FONR is outdated, potentially delisted? Maybe it is available on other exchange?
FONR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 202.3 million | 46.0 million |
| Sept. 30, 2023 | 201.6 million | 47.5 million |
| June 30, 2023 | 200.6 million | 49.8 million |
| March 31, 2023 | 199.3 million | 48.7 million |
FONR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | 3.9 million | ? |
| Sept. 30, 2023 | 2.5 million | 3.6 million |
| June 30, 2023 | 3.6 million | 29.6 million |
| March 31, 2023 | 2.1 million | ? |
FONR Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | 4.6 million |
| Sept. 30, 2023 | 5.4 million |
| June 30, 2023 | 2.2 million |
| March 31, 2023 | 4.5 million |
FONR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 53.3 million | - | 35.7 million |
| Sept. 30, 2023 | 51.7 million | - | 36.6 million |
| June 30, 2023 | 51.3 million | - | 36.8 million |
| March 31, 2023 | 49.7 million | 126000 | 37.5 million |
FONR Shares Outstanding
FONR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | 133000 | 416000 | 5.6 million | - |
| Sept. 30, 2023 | 79000 | 467000 | 4.9 million | - |
| June 30, 2023 | 697655 | 441749 | 9.3 million | - |
| March 31, 2023 | 2.2 million | 435000 | 7.1 million | - |
FONR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 25.4 million | 14.5 million |
| Sept. 30, 2023 | 2.0 million | 4.4 million |
| June 30, 2023 | 25.8 million | 13.5 million |
| March 31, 2023 | 25.4 million | 13.7 million |
FONR
Price: $19.09
52 week price:
Earnings Per Share: 1.15 USD
P/E Ratio: 16.08
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 3700
Ebitda: 23.0 millionMarket Capitalization: 117.8 million